JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A8551 INK 128 (MLN0128)
4 Citation

Target: mTOR

Summary: MTOR(TORC-1/-2) inhibitor,potent and selective

insoluble in H2O; ≥15.45 mg/mL
A8616 A-674563

Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSK

Summary: Akt1/PKA/CDK2 inhibitor,potent and selective

insoluble in EtOH; ≥23.8 mg/mL
A8627 Bafilomycin A1
32 Citation

Summary: V-ATPases inhibitor

Soluble in DMSO
A8650 Saxagliptin

Target: DPP-4

Summary: Selective DPP4 inhibitor
A8658 AY 9944 dihydrochloride

Summary: Hedgehog Inhibitor

Soluble in H2O
B1585 SC-514

Summary: ATP-competitive IKK-2 inhibitor, orally active

insoluble in EtOH; insoluble in H2O; ≥50.4 mg/mL
B2307 LGK-974
5 Citation

Summary: PORCN inhibitor,potent and specific

insoluble in H2O; ≥19.8 mg/mL
B2282 KX2-391
1 Citation

Summary: Src inhibitor,highly selective

insoluble in H2O; ≥121 mg/mL
B1011 Bafetinib (INNO-406)
2 Citation

Summary: Bcr-Abl/Lyn tyrosine kinase inhibitor

≥57.7 mg/mL
B1498 I-BET-762
4 Citation

Target: Bromodomains

Summary: BET inhibitor,highly potent

≥21.19 mg/mL